Literature DB >> 23194209

A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.

G V Cammu1, V Smet, K De Jongh, D Vandeput.   

Abstract

Six years ago, a study performed in our department reported that the incidence of postoperative residual curarisation (PORC) was 39%. The reassessment of neuromuscular monitoring and reversal of neuromuscular block in routine anaesthetic practice is relevant now that sugammadex has become available. The incidence of PORC, defined by a train-of-four (TOF) <90%, was evaluated at post-anaesthesia care unit (PACU) arrival in patients whose neuromuscular block had been reversed with neostigmine or sugammadex and those in whom reversal was felt unnecessary (adequate spontaneous recovery). During the PACU stay we recorded the oxygen saturation (SpO(2)) at arrival, episodes of SpO(2) <90%, airway manoeuvres and/or stimulation required to maintain SpO(2) >90%, and the need for re-intubation. In total, 624 patients were studied. Fifteen percent (66/441) of the patients who were not reversed, 15% (21/139) of those who were reversed with neostigmine and 2% (1/44) of those who received sugammadex exhibited PORC (P=0.06). No patient required reintubation in the PACU. The absence of neuromuscular monitoring and pharmacological reversal before extubation were not associated with PORC. A TOF <90% at PACU arrival was not associated with SpO(2) <90% during the PACU stay. Body mass index was the only independent predictor of SpO(2) <90% during the stay in the PACU. These findings indicate that in recent years, the incidence of PORC, defined by a TOF <90%, has dramatically decreased in our institution. The differences in PORC were not statistically significant between patients who received sugammadex for reversal and patients with spontaneous recovery or neostigmine reversal.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23194209     DOI: 10.1177/0310057X1204000611

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  9 in total

1.  Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.

Authors:  Brandon M Togioka; Katie J Schenning
Journal:  Drugs Aging       Date:  2022-08-08       Impact factor: 4.271

2.  Prevention of Postoperative Events following Reversal with Sugammadex or Neostigmine (the P-PERSoN Trial): Pilot Data Following Early Termination of a Prospective, Blinded, Randomised Trial.

Authors:  Benjamin Olesnicky; Matthew Doane; Clare Farrell; Greg Knoblanche; Anthony Delaney
Journal:  Anesthesiol Res Pract       Date:  2022-07-08

Review 3.  Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications.

Authors:  Sung-Ae Cho; Tae-Yun Sung
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-22

4.  International survey of neuromuscular monitoring in two European countries: a questionnaire study among Hungarian and Romanian anaesthesiologists.

Authors:  Adrienn Pongrácz; Réka Nemes; Caius Breazu; László Asztalos; Ileana Mitre; Edömér Tassonyi; Béla Fülesdi; Calin Mitre
Journal:  Rom J Anaesth Intensive Care       Date:  2019-04

5.  Effects of Sugammadex on Post-Operative Pulmonary Complications in Laparoscopic Gastrectomy: A Retrospective Cohort Study.

Authors:  Jiwon Han; Jung-Hee Ryu; Bon-Wook Koo; Sun Woo Nam; Sang-Il Cho; Ah-Young Oh
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

6.  Effect of sugammadex on chest radiographic abnormality in the early postoperative period after video-assisted thoracoscopic lobectomy

Authors:  Dong Kyu Lee; Sung Wook Kang; Hyun Koo Kim; Hyo Sung Kim; Heezoo Kim
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

Review 7.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

Review 8.  Sugammadex: Appropriate Use in the Context of Budgetary Constraints.

Authors:  Guy Cammu
Journal:  Curr Anesthesiol Rep       Date:  2018-03-20

9.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.